|
Tanox Incorporated, based in Houston, Texas, is a biopharmaceutical company that focuses on the development of therapeutic monoclonal antibodies. The company's drugs are employed in treating asthma, allergies, inflammation, and cancer. It is known for its Xolair (R) anti-IgE antibody product. Its TNX-355 anti-CD4 monoclonal antibody, in clinical trials in 2005, was developed to treat HIV and AIDS. Tanox maintains manufacturing operations in San Diego, California. The facility includes two 2,750-liter bioreactors, a 500-liter bioreactor, and a process development laboratory. The company's Houston manufacturing unit houses a 1,500-liter bioreactor. Tanox is listed on NASDAQ under the TNOX symbol.
|